Grandfield & Dodd, LLC Eli Lilly & CO Transaction History

Grandfield & Dodd, LLC

$1.58 Billion
Q3 2024

A detailed history of Grandfield & Dodd, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 2,699 shares of LLY stock, worth $2.02 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,699

Previous 2,748 1.78%

Holding current value

$2.02 Million

Previous $2.49 Million 3.86%

% of portfolio

0.15%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $37,834 - $47,040	-49 Reduced 1.78%	2,699 $2.39 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $102,931 - $129,083	-142 Reduced 4.91%	2,748 $2.49 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $41,454 - $55,459	-70 Reduced 2.36%	2,890 $2.25 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $74,576 - $87,916	-142 Reduced 4.58%	2,960 $1.73 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $16,953 - $23,372	-39 Reduced 1.24%	3,102 $1.67 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $56,118 - $75,036	-160 Reduced 4.85%	3,141 $1.47 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $122,189 - $142,374	380 Added 13.01%	3,301 $0
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $41,809 - $49,090	-150 Reduced 4.88%	2,921 $950,000
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $20,763 - $26,857	115 Added 3.89%	3,071 $700,000
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $11,502 - $14,890	70 Added 2.43%	2,956 $550,000
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $29,244 - $33,826	-200 Reduced 6.48%	2,886 $430,000
Q2 2020 Jul 24, 2020	BUY	$136.42 - $164.18 $7,230 - $8,701	53 Added 1.75%	3,086 $510,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $337,149 - $417,295	-2,832 Reduced 48.29%	3,033 $421,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $9,622 - $11,918	90 Added 1.56%	5,865 $771,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $16,018 - $17,424	-150 Reduced 2.53%	5,775 $646,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $22,158 - $25,864	-200 Reduced 3.27%	5,925 $656,000
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $33,393 - $39,306	-300 Reduced 4.67%	6,125 $795,000
Q2 2018 Jul 27, 2018	BUY	$75.7 - $86.88 $6,964 - $7,992	92 Added 1.45%	6,425 $548,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $488,084 - $541,724	6,333	6,333 $542,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Eli Lilly & CO Transaction History